Cargando…
Price trends of reimbursed oncological drugs in Switzerland in 2005–2019: A descriptive analysis
Increasing oncological treatment costs are a major global concern with the risk of entailing two-tiered health care. Among cost determining factors is the price of individual drugs. In recognition of the central role of this factor, we present a comprehensive overview of the development of monthly p...
Autores principales: | Rachamin, Yael, Ackermann, Christoph Jakob, Senn, Oliver, Grischott, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592494/ https://www.ncbi.nlm.nih.gov/pubmed/34780556 http://dx.doi.org/10.1371/journal.pone.0259936 |
Ejemplares similares
-
Correction: Price trends of reimbursed oncological drugs in Switzerland in 2005–2019: A descriptive analysis
Publicado: (2022) -
Impact of the COVID-19 Pandemic on Elective and Emergency Inpatient Procedure Volumes in Switzerland – A Retrospective Study Based on Insurance Claims Data
por: Rachamin, Yael, et al.
Publicado: (2022) -
The Impact of COVID-19 on Mental Healthcare Utilization in Switzerland Was Strongest Among Young Females—Retrospective Study in 2018–2020
por: Rachamin, Yael, et al.
Publicado: (2023) -
Pricing and reimbursement of novel oncology drugs in Sweden
por: Haglund, Mattias, et al.
Publicado: (2014) -
Prescription Rates, Polypharmacy and Prescriber Variability in Swiss General Practice—A Cross-Sectional Database Study
por: Rachamin, Yael, et al.
Publicado: (2022)